The Patent Finder

Terms ending in 2043

AbbVie Inc.

Every in-force patent on AbbVie Inc.'s record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,964,9901,3,4,7-Tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[2,3-b][1,4]oxazepine Bcl-2 Inhibitors
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 12,655,210Anti-Hemojuvelin (HJV) Antibodies for Treating Anemia of Chronic Disease
In force
 · High confidence
AbbVie Deutschland GmbH & Co. KGIn forceHigh confidence
US 12,172,992Pyrimidines for Degrading Bruton's Tyrosine Kinase
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 11,993,613Thiazolo[5,4-b]pyridine MALT-1 Inhibitors
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 12,121,589ANTI-CD19 Antibody Drug Conjugates
In force
 · High confidence
AbbVie Biotherapeutics Inc.In forceHigh confidence
US 12,478,689ANTI-CD19 Antibody Drug Conjugates
In force
 · Medium confidence
AbbVie Biotherapeutics Inc.In forceMedium confidence
US 12,799,192Risankizumab Compositions
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 12,157,776Anti-Papp-A Antibodies and Methods of Use Thereof
In force
 · High confidence
Calico Life Sciences LLCIn forceHigh confidence
8 of 8 patents shown. Soonest term end first, then patent number.
7 of these are in force and held by AbbVie Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited